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Abstract
Background: The deafness-associated gene mutation profile varies greatly among regions and races. Due to the
multi-ethnic coalition of over one thousand years, non-syndromic deafness (NSD) patients of Uyghur ethnicity may
exhibit a unique deafness-associated gene mutation spectrum as compared to Han Chinese deaf population.
Methods: In order to characterize nine loci of four deafness-associated genes of Uyghur NSD patients in
comparison with Chinese Han deaf population, NSD patients (n = 350) were enrolled, including Uyghur (n = 199)
and Han Chinese (n = 151). Following the history taking, blood samples were collected for DNA extraction. DNA
microarray was performed on nine loci of four deafness-associated genes, including 35delG, 176-191del16, 235delC,
299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples that showed the
absence of both wild and mutant probe signals were tested for further DNA sequencing analysis.
Results: The mutations in the nine loci of prevalent deafness-associated genes were detected in 13.06% of Uyghur
NSD patients and 32.45% of Han Chinese patients (P < 0.05), respectively. GJB2 mutation was detected in 9.05% of
Uyghur patients and 16.56% of Han Chinese patients (P > 0.05), respectively. 235delC was the hotspot mutation region
in NSD patients of the two ethnicities, whereas 35delG was the mutation hotspot in Uyghur patients. 187delG mutation
was detected for the first time in Uyghur NSD patients and considered as an unreported pathological variant of GJB2.
SLC26A4 mutation was found in 2.01% of Uyghur patients and 14.57% of Han Chinese patients (P < 0.05), respectively.
The frequencies of mtDNA 12S rRNA mutation in Uyghur and Han Chinese patients were 2.01% and 2.65% (P >0 . 0 5 ) ,
respectively. The NSD patients exhibited a low frequency of GJB3 mutation regardless of ethnicity.
Conclusion: Prevalent deafness-associated gene mutations in the nine loci studied were less frequently detected
in Uyghur NSD patients than in Han Chinese patients. GJB2 was the most common mutant gene in the two
ethnicities, whilst the two ethnicities differed substantially in hotspot mutations. A low-frequency SLC26A4 mutation
was detected in Uyghur NSD patients. Uyghur NSD patients differed significantly from Han Chinese patients in
gene mutation profile.
Background
Deafness is a worldwide prevalent disease that seriously
impairs human quality of life. The global incidence of con-
genital deafness is 1-3 per 1,000 newborns. The epidemio-
logical studies show that one half of deafness at childhood
is associated with genetic factors [1,2]. Non-syndromic
deafness (NSD) is the most common neurosensory deaf-
ness, and accounts for 70% of inherited hearing impair-
ment [3]. Until now, more than 200 genes have been
associated with NSD, including 36 autosomal recessive
genes, 24 autosomal dominant genes, and two X-linked
genes (http://hereditaryhearingloss.org/, updated in
October 2010).
The deafness-associated gene mutation spectrum as
well as dominant gene profile vary greatly among regions
and races [4,5]. 35de1G, 167de1T, and 235de1C are
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Caucasian, Jewish, and Asian populations, respectively
[6-8]. The epidemiological studies demonstrate that a
large proportion of NSD can be caused by a relative
small number of mutant genes, including GJB2,
SLC26A4, and mtDNA 12S rRNA [9-13]. A positive
result is very likely to be obtained by scanning the hot-
spot mutations of these genes alone. Microarray chip
technology is a high-throughput and high-efficiency tool
for the detection of gene mutations. CapitalBio Corpora-
tion (Beijing, China) develops a microarray chip that is
designated to detect mutation hotspots of inherited deaf-
ness in Chinese population, based on the large-scale epi-
demiological study data across 28 provinces and
municipalities from Chinese People’s Liberation Army
General Hospital [14-16]. This microarray chip allows
the simultaneous detection of nine loci of four deafness-
associated genes, namely, 35delG, 176-191del16, 235delC
and 299-300delAT for GJB2 gene, 538C > T for GJB3
gene, 1555A > G and 1494C > T for mtDNA 12S rRNA
gene, and 2168A > G (H723R) and IVS7-2A > G for
SLC26A4 gene.
Xinjiang is located on the northwest border of China,
where central and western Asian cultures converge. It is a
region populated by a variety of ethnicities but mainly by
Uyghur ethnicity. The deafness-associated gene mutation
spectrum and dominant mutation profile may be unique
in Uyghur population residing in Xinjiang due to the
multi-ethnic coalition over one thousand years. In this
study, we use the aforementioned microarray chip to
examine and analyze nine loci of four deafness-associated
genes among Uyghur and Han Chinese NSD patients
residing in Xinjiang, in aiming to characterize nine loci of
four deafness-associated genes of Uyghur NSD patients in
comparison with Han Chinese patients.
Materials and methods
Patients and DNA samples
The study protocol was approved by the Institutional
Review Board at the First Affiliated Hospital of Xinjiang
Medical University. The subjects, or their legal guardians
in the case of subjects under 18 years, volunteered to give
informed consent. Subjects were enrolled from the repre-
sentative deaf populations registered with Xinjiang local
institutes, including Kashi Municipal Special Education
School, Kashi Municipal Disabled People’s Association,
Changji Municipal Special Education School, Urumqi Lin-
gual Training School, and Otorhinolaryngology Outpatient
Clinic, the First Affiliated Hospital of Xinjiang Medical
University. Parents were inquired for a full history, includ-
ing family history, pregnancy/labor process, age of onset/
diagnosis, and previous history of infection, head trauma
and medication with aminoglycosides. Deaf patients
received routine physical and otorhinolaryngoloical exami-
nation, as well as pure tone audiometry. Brainstem audi-
tory evoked potential test was performed in uncooperative
children. Only biologically unrelated NSD patients (n =
350) who exhibited bilateral moderate or severe sensori-
neural hearing impairment on pure tone audiometry or
brainstem auditory evoked potential test were included.
Parents of NSD children were excluded from this study.
The ethnicity was determined based on the institutional
household records. Healthy volunteers of both Uyghur (n
= 103) and Han Chinese ethnicities (n = 70) who resided
in Xinjiang and exhibited normal hearing were enrolled as
control subjects. Peripheral venous blood samples (3-5 ml)
were collected from both NSD patients and control
subjects.
Mutational analysis with PCR
Genomic DNA was extracted from peripheral blood leu-
kocytes using a commercial available DNA isolation kit
(Tiangen Biotech Corporation, Beijing, China). The con-
centration and purity of DNA were determined using an
ultraviolet spectrometry (ActGene Inc, Taipei, Taiwan).
Polymerase chained reaction, chip hybridization, and chip
scan were conducted as recommended by the manufac-
turer of the microarray kit (CapitalBio Corporation, Beij-
ing, China) for the simultaneous detection of nine hotspot
mutations in four most prevalent NSD-associated genes,
including GJB2 (35delG, 176-191del16, 235delC, and 299-
300delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and
2168A > G), and mitochondrial 12S rRNA (1555A > G
and 1494C > T). The test results were determined based
on the fluorescent hybridization signal and the distribution
of microarray probe. In the case of the deletion at any
locus, the DNA sample was further sequenced by using an
ABI 3730XL analyzer (ABI, Foster, USA).
Statistical analysis
The statistical analysis was performed using SPSS 17.0
(SPSS Inc., Chicago, USA). The intergroup difference in
frequency was compared using the two-tailed chi-square
test or Fisher’s exact probability test. A P-value less than
0.05 was considered statistically significant.
Results
In this study, the NSD population (n = 350) included 199
Uyghur patients (86 males and 113 females), aged 12.7 ±
5.3 years (range, 1-35), and 151 Han Chinese patients (86
males and 65 females), aged 10.9 ± 5.4 years (1-26). Out
of 350 patients, 33 patients had a family history of deaf-
ness, whose siblings, parents, or other close relatives
were also deaf, including 22 Uyghur and 11 Han Chinese
subjects. The remaining 317 cases were determined to be
sporadic.
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patients and control subjects
Out of 199 Uyghur patients, 22 (11.1%) patients exhibited
mutations in one allele or more. The deletion of both
mutant and wild probe signal was detected in four (2.0%)
Uyghur patients. This suggested that the possible presence
of new mutant locus failed the effective binding of hybridi-
zation prime to the DNA sequence of the test sample. The
further gene sequencing identified 187delG/187delG for
GJB2 in three patients (Figure 1A), and 1503G > A for
mtDNA 12S rRNA in one patient (Figure 1B). The homo-
genous mutations identified in these four patients were,
therefore, included as positive test results (Table 1). The
frequencies of prevalent deafness-associated gene muta-
tions in the nine loci were 13.06%, 1.94%, 32.45% and
4.28% in Uyghur patients, Uyghur control subjects, Han
Chinese patients, and Han Chinese control subjects,
respectively (Table 2). The mutation frequency was signifi-
cantly lower in Uyghur patients than in Han Chinese
patients (c
2 = 19.162, P < 0.05). Moreover, the mutations
were also more frequently detected in the patient popula-
tion than in control subjects for either ethnicity (c
2 =
9.983, P < 0.05; c
2 = 21.086, P < 0.05).
Multination of deafness-associated gene loci in NSD
patients and control subjects
The frequencies of mutations for GJB2, SLC26A4,
mtDNA 12S rRNA and GJB3 in the two ethnicities were
shown in Table 3. The mutant genotypes of the four
deafness-associated genes in Uyghur patients, Uyghur
control subjects, Han Chinese patients, and Han Chinese
control subjects were presented in Table 4.
The frequency of GJB2 multination was 9.05% (18/199)
in Uyghur patients, involving three mutations, namely,
235delC, 35delG, and 187delG. The allele frequencies
were 3.52% (14/398), 2.26% (9/398) and 1.51% (6/398) in
Uyghur patients, respectively. 235delC showed the highest
frequency, whilst 187delG was identified for the first time
in Uyghur NSD patients, and considered as an unreported
pathological mutation of GJB2.T h eGJB2 mutation
frequency in Han Chinese patients was 16.56% (25/151),
also involving three mutations, namely, 235delC, 299-
300delAT, and 176-191del16. The allele frequencies were
9.93% (30/302), 2.32% (7/302) and 0.33% (1/302) in Han
Chinese patients, respectively. The mutation frequencies
of GJB2 were 1.94% (2/103) and 4.28% (3/70) in Uyghur
and Han Chinese control subjects (c
2 = 4.495, P > 0. 05),
respectively. The allele frequency of 235delC was signifi-
cantly higher in Han Chinese patients than in Uyghur
patients (c
2 =1 2 . 0 0 0 ,P < 0. 05), whereas that of 35delG
was significantly higher in Uyghur patients than in Han
Chinese patients (Fisher’s exact probability test, P <0 .0 5 ) .
The frequencies of SLC26A4 mutation, including 2168A
> G (H723R) and IVS7-2A > G, were 2.01% (4/199) in
Uyghur patients and 14.57% (22/151) in Han Chinese
patients, respectively. Of note, IVS7-2A > G mutant alleles
accounted for 83.33% (25/30) of SLC26A4 mutation in
Han Chinese patients. SLC26A4 mutation was less fre-
quently found in Uyghur patients than in Han Chinese
patients (c
2 = 19.694, P < 0.05).
Figure 1 DNA sequence chromatograms of homozygous mutations in patients with nonsyndromic deafness: (A) 187delG and (B)
1503G > A.
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including 1555A > G and 1494C > T, were 2.01% (4/199)
in Uyghur patients and 2.65% (4/151) in Han Chinese
patients, respectively. The homozygous mutation of 1503
G > A was an unreported gene mutation. The mutation
frequencies of 538C > T for GJB3 were 0.0% (0/199) in
Uyghur patients and 1.32% (2/151) in Han Chinese
patients. The mutation frequencies of mtDNA 12S rRNA
and GJB3 were relatively low in both Uyghur and Han
Chinese patients (Fisher’s exact probability test, P >0 .0 5 ) .
Mutation profiles of NSD patients with a definitive family
history of deafness
Among Uyghur patients (n = 22) with a family history of
deafness, the gene mutation in any of the nine loci studied
was found in three (3/22, 13.64%) patients. In contrast, out
of eleven Han Chinese patients with a family history of
deafness, six patients (6/11, 54.55%) were found to carry
t h eg e n em u t a t i o ni na n yo ft h en i n el o c i .M o s to ft h e s e
mutations were homozygous, homogenous, and double or
compound heterozygous. For patients with a family history
of deafness, the frequencies of gene mutations in the nine
loci studied were significantly higher in Han Chinese
patients than in Uyghur patients (Fisher’s exact probability
test, P < 0. 05).
Discussion
In our study, the mutation frequencies of the nine loci for
the four prevalent deafness-associated genes are 13.06% in
Uyghur patients, 1.94% in Uyghur control subjects, 32.45%
in Han Chinese patients, and 4.28% in Han Chinese con-
trol subjects, respectively. The mutation frequencies are
significantly higher in NSD patients than in control sub-
jects for either ethnicity, supporting the profound role of
prevalent deafness-associated genetic testing in the etiolo-
gical diagnosis of NSD patients. Moreover, the mutation
frequency is significantly lower in Uyghur patients than in
Han Chinese patients, requiring the further analysis of
deafness-associated genes and mutation hotspots for the
two ethnicities.
GJB2 gene encodes CX-26, a connexin associated with
the formation of gap junction and osmolality. As Cx-26
is highly expressed on human cochlear hairy cells, GJB2
gene mutation is believed to be closely associated with
NSD. GJB2 mutation prevails among deaf people across
regions and races [17]. It is reported that GJB2 mutation
accounts for over 50% of autosomal recessive inherited
deafness cases [2,8]. Dai et al [18] reported that the fre-
quency of GJB2 mutation was 4.0-30.4% in Chinese NSD
patients. In our study, the mutation frequencies of GJB2
are 9.05% Uyghur patients and 16.56% for Han Chinese
patients, in consistence with the report of Dai et al. In
contrast to SLC26A4, mtDNA 12S rRNA and GJB3, GJB2
exhibits the highest mutation frequency in the two ethni-
cities, justifying that GJB2 remains the primary deafness-
associated gene in both Uyghur and Han Chinese NSD
patients. The mutant loci and allele frequencies differ sig-
nificantly between the two ethnicities, whereas the overall
mutation frequency of GJB2 mutation is comparable.
Among the three mutations of GJB2 found in Uyghur
patients, 235delC shows the highest allele frequency, and
35delG follows 235delC in allele frequency. 235delC is
reported to be the major mutation among Eastern Asians
[19-21], whereas 35delG is the hotspot mutation in Cau-
casians. Homozygous or heterozygous 35de1G mutation
is also found in Western Asians, an extended family of
Caucasian [22,23]. Both 235delC and 35delG are simulta-
neously identified as the predominant mutations in
Uyghur NSD patients, which is probably attributed to the
ethnic origin of Uyghur people. Located close to Central
Asia, Kashi is an important stop of the ancient Silk Road.
Uyghur people have mixed 30% of Caucasian kinship
through the migration and cross-ethnic marriage, render-
ing themselves the Caucasian and Mongolian characters
simultaneously [24]. Among the three mutations detected
in Han Chinese NSD patients, 235delC has the highest
allele frequency, consistent with the fact that 235delC is
Table 1 Genotypes of deleted loci in patients with nonsyndromic deafness
Deleted loci Mutant loci confirmed on sequencing analysis Samples size
176-191del16 (GJB2) 187delG/187delG 3
1494C > T (12S rRNA) 1503G > A 1
Table 2 Mutation frequencies of prevalent genes in
Uyghur and Han Chinese patients with nonsyndromic
deafness and control subjects
Study subjects n n of mutation Rate
Uyghur patients 199 26 13.06%
Han Chinese patients 151 49 32.45%
Uyghur control subjects 103 2 1.94%
Han Chinese control subjects 70 3 4.28%
Table 3 Detection rates of deafness-associated gene
mutations among Uyghur and Han Chinese patients with
nonsyndromic deafness
Patient group n Number of positive samples (%)
GJB2 SLC26A4 12S rRNA GJB3
Uyghur 199 18 (9.05%) 4 (2.01%) 4 (2.01%) 0 (0.0%)
Han Chinese 151 25 (16.56%) 22 (14.57%) 4 (2.65%) 2 (1.32%)
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study, 187delG is found in Uyghur NSD patients for the
first time and considered as an unreported pathogenetic
mutation of GJB2 (http://davinci.crg.es/deafness/,
updated in January 2011). 187delG mutation results in
the frameshift mutation of codon and the subsequent
production of inactive connexin. Mutant proteins may
cause the dysregulation of pH, decrease the permeability
of gap junction, and consequently lead to hearing impair-
ment. The allele frequency of 187delG is 1.51% (6/398),
manifesting as homozygous mutations in the three
Uyghur patients. Two of the three patients were borne by
the couples in consanguineous marriages who have nor-
mal hearing otherwise. It suggests that all these parents
are potential carriers. It is likely that 187delG is a com-
mon mutation among Uyghur NSD patients.
As a major sensorineural deafness-associated gene that
is discovered following the identification of GJB2,
SLC26A4 mutation is associated with the dilation of ves-
tibular aqueduct in NSD [25] and accounts for 4-15% of
inherited deafness cases [1,26]. In Western deaf popula-
tion, L236P, T416P, E384G, and IVS8+1G > A are com-
mon mutant loci of SLC26A4 [21], whereas 2168A > G is
the primary mutant locus in Japanese and Korean deaf
patients [27,28]. IVS7-2 A > G is reported to be the
major mutant locus of SLC26A4 in Han Chinese deaf
population as well [15,29]. In our study, the two locus
mutations of SLC26A4, namely, IVS7-2A > G and 2168A
> G (H723R), are less frequently found in Uyghur NSD
patients, whereas IVS7-2A > G is the primary mutation
in Uyghur patients. Dai et al. [15] reported the complete
absence of IVS7-2A > G mutation in 60 Uyghur patients.
Li et al. [30] reported that IVS7-2A > G, a major mutant
locus of SLC26A4 exhibited a relatively low frequency
among Northwestern Chinese ethnicities, including
Uyghur people. This finding shows a low carrier fre-
quency of the two SLC26A4 locus mutations in Uyghur
population. The mutation frequency of SLC26A4 is
14.57% (22/151) in Han Chinese NSD patients, whilst
IVS7-2A > G mutant alleles account for 83.33% (25/30)
among SLC26A4 mutation. This is consistent with the
report that IVS7-2A > G is the primary mutation of
SLC26A4 in Han Chinese NSD patients. The frequency
of SLC26A4 mutation differs significantly between the
two ethnicities. The low-frequency SLC26A4 mutation in
U y g h u rN S Dp a t i e n t si si n c o n s i s t e n tw i t ht h ef a c tt h a t
SLC26A4 is one of the major sensorineural deafness-
associated genes. It can be inferred that Uyghur NDS
patients differ from Mongolian ethnicity in the hotspot
mutation of SLC26A4. Whether Uyghur patients share
Table 4 Genotypes of prevalent gene mutations in nonsyndromic deafness patients and control subjects of Uyghur
and Han Chinese ethnicities
Genotype Uyghur patients
(n)
Han Chinese patients
(n)
Uyghur control subjects
(n)
Han Chinese
control subjects (n)
235delC/- 4 9 1 2
235delC/235delC 3 6 0 0
35delG/- 3 0 0 0
35delG/35delG 1 0 0 0
1555A > G 3 3 0 0
1494C > T 0 1 0 0
IVS7-2A > G/- 0 7 0 0
IVS7-2A > G/IVS7-2A > G 2 7 0 0
2168A > G/- 1 3 1 0
2168A > G/IVS7-2A > G 1 1 0 0
235delC/35delG 4 0 0 0
235delC/299-300delAT 0 5 0 0
235delC/176-191del16 0 1 0 0
235delC/IVS7-2A > G 0 1 0 0
235delC/2168A > G 0 1 0 0
235delC/299-300delAT/
IVS7-2A > G
01 0 0
IVS7-2A > G/538C > T 0 1 0 0
299-300delAT/- 0 1 0 1
538C > T/- 0 1 0 0
187delG/187delG 3 0 0 0
1503G > A 1 0 0 0
Total 26 49 2 3
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population remains yet to be investigated.
As a matrilineal mitochondrial gene, mtDNA 12S rRNA
is associated with aminoglycoside-induced deafness
[31,32]. 1555A > G and 1494C > T are the most important
and common mutations. 1555A > G is more frequently
detected, but shows a variable prevalence probably due to
the ethnic variation in the susceptibility to aminoglycoside
toxicity [33]. Both Spanish and Japanese severe progressive
deaf populations show a relatively low-frequency 1555A >
Gm u t a t i o n[ 3 4 , 3 5 ] ,i nc o m p a r i s o nw i t haf r e q u e n c yo f
2.9-13.0% reported by Li et al. [11]. The mutation fre-
quency of 1494C > T is even lower than that of 1555A >
G. 1494C > T mutation is detected in only one Han Chi-
nese patient in contrast to the ‘zero’ reported by Li et al.
[11]. The mutation frequency of mtDNA 12S rRNA is sta-
tistically comparable between the two ethnicities. The
unreported 1503G > A homogenous mutation that is
found in one Uyghur NSD patient requires the further
analysis to delineate whether it is a pathogenetic mutation.
GJB3 is a gene associated with NSD, and is initially
cloned by Xia et al. [36]. GJB3 mutation is associated with
the high-frequency hearing impairment in an autosomal
dominant or recessive inheritance pattern [37]. GJB3
mutation is rarely detected in European and North Ameri-
can populations [38]. 538C > T mutation of GJB3 is
detected in two of Han Chinese patients, but not in
Uyghur patients or control subjects, showing a insignifi-
cant difference in the frequency of GJB3 mutation between
the two ethnicities though.
The mutation frequencies of the nine loci in patients
with a definitive family history of deafness are 13.64%
for Uyghur and 54.55% for Han Chinese, respectively.
The low mutation frequency in Uyghur NSD patients
suggests that some mutations occurring at other loci or
in other deafness-associated genes may be implicated in
this ethnic group.
Conclusion
Our study show that Uyghur NSD patients differ signifi-
cantly from Han Chinese patients in deafness-associated
gene mutation spectrum. Therefore, the further gene
sequencing analysis and pedigree analysis are required
to examine the mutation profile and determine the pre-
dominant mutations in Uyghur NSD patients.
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